← FDA DRUG APPROVALS

FDA ANDA · ANDA071192

AMINOCAPROIC ACID

Sponsor: LUITPOLD

APPLICATION
ANDA071192
TYPE
ANDA
ORIGINAL APPROVAL
1987-12-01
LATEST ACTION
2007-02-26
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

AMINOCAPROIC ACIDPrescription
AMINOCAPROIC ACID 250MG/ML · INJECTABLE · INJECTION

Approval history

2007-02-26Labeling · Supplement 12AP
2000-02-04Labeling · Supplement 7AP
1999-10-19Labeling · Supplement 6AP
1997-08-28Manufacturing (CMC) · Supplement 5AP
1996-02-28Manufacturing (CMC) · Supplement 4AP
1994-06-28Manufacturing (CMC) · Supplement 3AP
1991-12-03Labeling · Supplement 2AP
1991-08-01Manufacturing (CMC) · Supplement 1AP
1987-12-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →